Surge
Surge provides clinicians with preoperative immune profiling that identifies patients at elevated risk of postoperative infections and pulmonary complications. The company performs single-cell immune assessment and immunological fingerprinting on small blood samples and applies a proprietary machine-learning algorithm (PreCyte) to combine cellular and clinical data into individualized risk predictions. Surge's platform is positioned as an immune-based diagnostic for perioperative risk stratification, discharge timing, and care-pathway optimization. The technology builds on single-cell and multi-omics immunology research and is deployed with academic medical centers to inform clinical decision-making.
Surge
Surge provides clinicians with preoperative immune profiling that identifies patients at elevated risk of postoperative infections and pulmonary complications. The company performs single-cell immune assessment and immunological fingerprinting on small blood samples and applies a proprietary machine-learning algorithm (PreCyte) to combine cellular and clinical data into individualized risk predictions. Surge's platform is positioned as an immune-based diagnostic for perioperative risk stratification, discharge timing, and care-pathway optimization. The technology builds on single-cell and multi-omics immunology research and is deployed with academic medical centers to inform clinical decision-making.